Tennor Therapeutics
PrivateLast Round
Series D
May 26, 2026
Total Funding Raised
$96.19M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Tennor Therapeutics is a biotechnology research company that discovers and develops novel multi-functional drugs for the treatment of cancers and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B2C
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Tennor Therapeutics Comparables
Compare Tennor Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Gurnet Point Capital | 75% | |
| RedHill Biopharma | 73% | |
| Spero Therapeutics, Inc. | 65% | |
Tennor Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | May 26, 2026 | ||||
| Series E | Oct 16, 2024 | ||||
| Series D Extension | Jan 5, 2023 | ||||
| Series D | Feb 25, 2022 | ||||
| Series C Extension | Jun 5, 2020 | ||||
Series C | Sep 19, 2016 |
Tennor Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| 中山创业投资有限公司 | Series E |
| AMR Action Fund | Series E |
| Yuanjing Investment | Series D Extension |
| Yanchuang Capital | Series D |
| Oriza Holdings | Series C Extension, Series B, Series D |
| Al Mal Investment Company | Series B |
| Northern Light Venture Capital | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 26, 2026
$15M raised in Seed Round.
- Oct 16, 2024
Raised $42.4M led by 中山创业投资有限公司
Tennor Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Tennor Therapeutics's valuation, stock price, and market status.